Mr. Speaker, I would like to thank the member.
I would say to just imagine this: We have a partner to manufacture a vaccine in Canada. It is called Novavax. It has chosen Canada out of all the jurisdictions in which it operates.
More interestingly, we also have a domestic company called Medicago in which we have invested $173 million to make sure that we will have a made-in-Canada vaccine. In addition to that, yesterday the Minister of Finance added another $2 billion to make sure that we could continue to invest in manufacturing, and to invest in the health and safety of all Canadians.